‘Alzheimer’s Disease’

Treatment of Alzheimer – Alzheimer’s Vaccine

Thursday, August 12th, 2010

Alzheimer VaccineA major effort has made several research groups to synthesize a vaccine available to prevent Alzheimer’s disease (AD).

In simple terms, the idea is to create in a laboratory, a protein that is very similar to proteins that normally are deposited in the brain of the sick patient and eventually cause the symptoms of dementia.

By exposing a healthy individual and any risk factors, such as a history of having close relatives with the EA, it creates antibodies created in the lab and also with proteins that are characteristic of AD.

This would prevent therefore, protein synthesis and deposition years later that will cause the first symptoms of dementia.

Already there have been many scientific studies and is expected to close in the future hopefully be approved this vaccine, which will undoubtedly be a great addition to the treatment of AD.

Galantamine: Another Alternative for the Treatment of Alzheimer

Soon more will be available in the Chilean market the drug Galantamine (Razadyne ER in the U.S.) and is part of the therapeutic alternatives for Alzheimer’s disease with early or intermediate. (more…)

Tags: , , , , ,
Posted in Alzheimer's Disease, Treatment of Alzheimer's | No Comments »

Treatment of Alzheimer’s: Arthritis Drug

Monday, August 9th, 2010

arthritis drugArthritis drug yields impressive results in the treatment of Alzheimer’s

Impressive are the findings derived from a study on Alzheimer’s by a team of U.S. scientists from the Universities of California at Los Angeles and Southern California: the application of a drug for arthritis managed to turn “in ten minutes” some signs of disease in a patient of 81 years.

The trade publication Journal of neuroinflammation (Journal of Neuroinflammation) reports that physicians applied to the spine of the patient an injection of Etanercept, a drug used to relieve pain and inflammation associated with rheumatoid arthritis.

The professionals said the patient, who was just beginning to exhibit the symptoms of the disease, could remember the name of your doctor along with the date and place where he was, but ten minutes before had been unable to do so.

However, Dr. Anthony Alvarez, the Biomedical Research Centre in Spain, called for caution with the subject.

“We must be cautious whenever we speak of the experience of a single patient,” he told the BBC the professional currently working on a vaccine against Alzheimer’s disease.

Notes also that it is necessary to show that the drug is safe and runs on a significant number of patients.

Tags: , , , ,
Posted in Alzheimer's Disease, Treatment of Alzheimer's | No Comments »

The music could improve memory in people with Alzheimer’s

Sunday, May 30th, 2010

The memory of those who suffer from Alzheimer’s disease could benefit thanks to the songs, because people with this disease seem to remember verbal information better if it is provided in a musical context.

In these compelling findings was a team of specialists from the University School of Medicine, Boston, who published his findings in the journal Neuropsychological.

THE BAD MEMORY

Alzheimer’s disease is the most common form of dementia. This chronic disease is strongly associated with age, and irreversibly develops as time passes.

Early symptoms include loss of memory and confusion, but when evil spreads arise personality changes, altered behavior and loss of cognitive abilities. People with this disease often do not recognize family members or have difficulty speaking, reading or doing everyday tasks such as combing hair or bathing. (more…)

Tags: , ,
Posted in Brain Diseases | 1 Comment »

Found two new genetic variants associated with Alzheimer

Monday, May 24th, 2010

A multicenter study is published today in JAMA has identified two genes that may be risk factors for development of Alzheimer’s disease late onset, although not help quantify the risk in carriers of these alterations.

Researchers at Boston University, U.S., in collaboration with scientists from the Rotterdam Study, coordinated by Monique Breteler, the Cardiovascular Health Study, led by Oscar Lopez, AGES-Reykjavik study, coordinated by Lenore Launer, the study in May AD , directed by Steve Younkin, the European Consortium of Alzheimer’s Disease, who leads Philippe Amouyel, the ACE Foundation in Barcelona, coordinated by Merce Boada, and the Consortium for Genetic and Environmental Risk of Alzheimer’s Disease, directed by Julie Williams, have identified two genes that may be risk factors for developing Alzheimer’s disease late onset.

The work, published today in The Journal of the American Medical Association, was carried out by analysis of genome wide association. The researchers have identified two new genes in specific locations in DNA. These genes appear to be independent of those already established by its association with the disease of Alzheimer’s, such as apolipoprotein E (APOE). (more…)

Tags: , , ,
Posted in Parkinson's Disease | No Comments »

Identify Areas of The Brain

Friday, May 7th, 2010

The research, carried out by a Spanish team, was awarded first prize at the III World Congress on Controversies in Neurology.

A group of Spanish researchers has identified the areas in the brain that are impaired when a neurodegenerative process is initiated and appears mild cognitive impairment. “The findings are relevant because they give us clues about the brain areas that we should look to in future make an early diagnosis of Alzheimer’s disease,” said Juan Antonio Hernandez Tamames, director of the Laboratory of Medical Image Analysis and Biometrics URJC center where images were analyzed in the study.

The research, carried out by the Universidad Rey Juan Carlos (URJC), in collaboration with Queen Sofia Foundation Alzheimer’s Project and the Department of Basic Psychology, National University of Distance Education (UNED), analyzed a total of 40 patients -18 and 22 healthy subjects with mild cognitive impairment-selected sample of 140 individuals used in the study, three-year Early detection of MCI and progression to Alzheimer’s Disease. Analysis of MCI subtype, markers, and Risk Factors. Patients with cognitive impairment were classified as amnestic, amnestic and multidomain not, ie those with amnesia problems and problems in the execution of daily tasks.

The work, which has received the first prize at the III World Congress on Controversies in Neurology held in the Czech Republic last October, shows that in subjects with mild cognitive impairment amnestic begins turning parahippocampal damage the brain – an area close to the memory and memories in the brain. (more…)

Tags: , , ,
Posted in Brain Diseases | 1 Comment »

Treatment for People with Alzheimer

Saturday, May 1st, 2010

The proper treatment of persons with Alzheimer’s disease is essential, even when suffering from memory loss. People with this condition miss events as a conversation or a joke, but the happy feelings associated with these moments may survive and improve their mood.

To these conclusions did a study at the University of Iowa (USA). “A simple visit or phone call by a relative may have a very positive influence on the happiness of patients, even if quickly forgotten the event. By contrast, negligence in the treatment given in an institution where they are interned could generate sadness, frustration and loneliness but can not remember why, “said Justin Feinstein, the lead author of the research.

Bad Brain

Alzheimer’s disease is a neurodegenerative disorder that is generated by the progressive deterioration and death of brain cells. This evil is strongly associated with age. The first symptoms often include memory loss and confusion, but it gets worse causing personality change, loss of cognitive skills and difficulty recognizing other people. (more…)

Tags: , , ,
Posted in Parkinson's Disease | 2 Comments »